In the present study, the in vitro experiments revealed the efficacy and mechanism of action AQB in combination with palbociclib on cell cycle inhibition in glioma cell lines, with a high expression of HOTAIR and EZH2, and a low expression of CWF19L1. Here, EZH2 is linked to glioma.